Literature DB >> 31700911

MYC gene associated polymorphisms and Wilms tumor risk in Chinese children: a four-center case-control study.

Jiabin Liu1, Rui-Xi Hua2, Wen Fu1, Jinhong Zhu1,3, Wei Jia1, Jiao Zhang4, Haixia Zhou5, Jiwen Cheng6, Huimin Xia1, Guochang Liu1, Jing He1.   

Abstract

BACKGROUND: Wilms tumor (WT) is a common embryonal malignancy in the kidney, ranking fourth in childhood cancer worldwide. MYC, a critical proto-oncogene, plays an important role in tumorigenesis. Single nucleotide polymorphisms in the MYC gene may lead to the deregulation of MYC proto-oncogene protein and thereby promote the initiation and development of tumors.
METHODS: Here, we assessed the association between MYC gene associated polymorphisms and WT susceptibility by performing a case-control study with 355 cases and 1070 controls. Two MYC gene associated polymorphisms (rs4645943 C > T, rs2070583 A > G) were genotyped by TaqMan technique. Odds ratios (ORs) and 95% confidence intervals (CIs) were used for evaluating the association between these two polymorphisms and WT susceptibility.
RESULTS: No significant association was detected between the selected polymorphisms and WT risk in the overall analysis as well as stratification analysis.
CONCLUSIONS: These results indicate that neither of two selected MYC gene associated polymorphisms might affect WT susceptibility in the Chinese population. Large well-designed studies with diverse ethnicities are warranted to verify these results. 2019 Annals of Translational Medicine. All rights reserved.

Entities:  

Keywords:  MYC; Wilms tumor (WT); polymorphism; susceptibility

Year:  2019        PMID: 31700911      PMCID: PMC6803173          DOI: 10.21037/atm.2019.08.31

Source DB:  PubMed          Journal:  Ann Transl Med        ISSN: 2305-5839


  53 in total

Review 1.  MYC as a regulator of ribosome biogenesis and protein synthesis.

Authors:  Jan van Riggelen; Alper Yetil; Dean W Felsher
Journal:  Nat Rev Cancer       Date:  2010-04       Impact factor: 60.716

2.  Multiple regions within 8q24 independently affect risk for prostate cancer.

Authors:  Christopher A Haiman; Nick Patterson; Matthew L Freedman; Simon R Myers; Malcolm C Pike; Alicja Waliszewska; Julie Neubauer; Arti Tandon; Christine Schirmer; Gavin J McDonald; Steven C Greenway; Daniel O Stram; Loic Le Marchand; Laurence N Kolonel; Melissa Frasco; David Wong; Loreall C Pooler; Kristin Ardlie; Ingrid Oakley-Girvan; Alice S Whittemore; Kathleen A Cooney; Esther M John; Sue A Ingles; David Altshuler; Brian E Henderson; David Reich
Journal:  Nat Genet       Date:  2007-04-01       Impact factor: 38.330

Review 3.  Reflecting on 25 years with MYC.

Authors:  Natalie Meyer; Linda Z Penn
Journal:  Nat Rev Cancer       Date:  2008-12       Impact factor: 60.716

Review 4.  Wilms tumor genetics.

Authors:  V Huff
Journal:  Am J Med Genet       Date:  1998-10-02

5.  Polymorphism of 8q24 rsl3281615 and breast cancer risk : a meta-analysis.

Authors:  Yan-Lei Pei; He-Long Zhang; Hong-Guang Han
Journal:  Tumour Biol       Date:  2012-11-07

6.  Correlation of MYC Gene and Protein Status With Breast Cancer Subtypes and Outcome of Patients Treated With Anthracycline-Based Adjuvant Chemotherapy. Pooled Analysis of 2 Hellenic Cooperative Group Phase III Trials.

Authors:  Anna Batistatou; Vassiliki Kotoula; Mattheos Bobos; George Kouvatseas; Flora Zagouri; Eleftheria Tsolaki; Helen Gogas; Angelos Koutras; George Pentheroudakis; Eleni Timotheadou; Stavroula Pervana; Anna Goussia; Kalliopi Petraki; Maria Sotiropoulou; Triantafyllia Koletsa; Evangelia Razis; Paris Kosmidis; Gerasimos Aravantinos; Christos Papadimitriou; Dimitrios Pectasides; George Fountzilas
Journal:  Clin Breast Cancer       Date:  2017-07-13       Impact factor: 3.225

7.  Familial Wilms' tumor: a descriptive study.

Authors:  N E Breslow; J Olson; J Moksness; J B Beckwith; P Grundy
Journal:  Med Pediatr Oncol       Date:  1996-11

8.  Genome-wide association scan identifies a colorectal cancer susceptibility locus on chromosome 8q24.

Authors:  Brent W Zanke; Celia M T Greenwood; Jagadish Rangrej; Rafal Kustra; Albert Tenesa; Susan M Farrington; James Prendergast; Sylviane Olschwang; Theodore Chiang; Edgar Crowdy; Vincent Ferretti; Philippe Laflamme; Saravanan Sundararajan; Stéphanie Roumy; Jean-François Olivier; Frédérick Robidoux; Robert Sladek; Alexandre Montpetit; Peter Campbell; Stephane Bezieau; Anne Marie O'Shea; George Zogopoulos; Michelle Cotterchio; Polly Newcomb; John McLaughlin; Ban Younghusband; Roger Green; Jane Green; Mary E M Porteous; Harry Campbell; Helene Blanche; Mourad Sahbatou; Emmanuel Tubacher; Catherine Bonaiti-Pellié; Bruno Buecher; Elio Riboli; Sebastien Kury; Stephen J Chanock; John Potter; Gilles Thomas; Steven Gallinger; Thomas J Hudson; Malcolm G Dunlop
Journal:  Nat Genet       Date:  2007-07-08       Impact factor: 38.330

9.  SNPeffect 4.0: on-line prediction of molecular and structural effects of protein-coding variants.

Authors:  Greet De Baets; Joost Van Durme; Joke Reumers; Sebastian Maurer-Stroh; Peter Vanhee; Joaquin Dopazo; Joost Schymkowitz; Frederic Rousseau
Journal:  Nucleic Acids Res       Date:  2011-11-10       Impact factor: 16.971

10.  Association between NER Pathway Gene Polymorphisms and Wilms Tumor Risk.

Authors:  Jinhong Zhu; Wen Fu; Wei Jia; Huimin Xia; Guo-Chang Liu; Jing He
Journal:  Mol Ther Nucleic Acids       Date:  2018-08-08       Impact factor: 8.886

View more
  2 in total

1.  Association between miR-492 rs2289030 G>C and susceptibility to Hirschsprung disease in southern Chinese children.

Authors:  Yi Zheng; Yanqing Liu; Mi Wang; Qiuming He; Xiaoli Xie; Lifeng Lu; Wei Zhong
Journal:  J Int Med Res       Date:  2020-10       Impact factor: 1.671

2.  Comprehensive bioinformatics analysis of the TP53 signaling pathway in Wilms' tumor.

Authors:  Changjing He; Huatao Qin; Haizhou Tang; Di Yang; Yufeng Li; Zhenwen Huang; Donghu Zhang; Changheng Lv
Journal:  Ann Transl Med       Date:  2020-10
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.